(MENAFN- The Conversation) Dr. Lexchin has been writing and publishing about pharmaceutical policy issues for the past 30 years. He is the author or co-author of over 140 peer-reviewed papers on a wide range of topics in this area, including: drug regulation, pharmacosurveillance, drug promotion, research and development, access to medications in developing countries and physician prescribing behaviour. He has been a consultant on these and other issues to the Ontario provincial government, various parts of the Canadian federal government, the government of New Zealand, the Australian National Prescribing Service and the World Health Organization.
Experience
- –present Affiliate - pharmaceutical policy, University of Sydney
Education
- 1977 University of Toronto, MD
MENAFN11052021000199003603ID1102067443
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.